Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Seres Therapeutics, Inc. amended Lease Amendment with 101 CPD LLC valued at approximately $33.9 million (effective 2026-06-04).
- Action
- amendment
- Agreement
- lease
- Counterparty
- 101 CPD LLC
- Value
- approximately $33.9 million
- Effective
- 2026-06-04
Exact text from the filing
On June 4, 2026, the Company entered into the First Amendment to Lease (the “Lease Amendment”) with 101 CPD LLC (f/k/a HCP/King 101 CPD LLC), a Delaware limited liability company (the “Landlord”), which amends the Lease Agreement, dated September 22, 2021, by and between the Company and the Landlord (as amended, the “Lease”), pursuant to which the Company leases approximately 82,714 rentable square feet of office and laboratory space located at 101 CambridgePark Drive, Cambridge, Massachusetts (the “Existing Premises”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Seres Therapeutics, Inc. amended APA Amendment with Société des Produits Nestlé S.A. valued at $25.0 million (effective 2026-06-02).
- Action
- amendment
- Agreement
- asset purchase
- Counterparty
- Société des Produits Nestlé S.A.
- Value
- $25.0 million
- Effective
- 2026-06-02
Exact text from the filing
On June 2, 2026, Seres Therapeutics, Inc. (the “Company”) entered into Amendment No. 1 (the “APA Amendment”) to the Asset Purchase Agreement, dated as of August 5, 2024 (as previously amended by that certain Letter Agreement, dated September 30, 2024 and that certain Letter Agreement, dated December 31, 2024, the “Purchase Agreement”), by and between the Company and Société des Produits Nestlé S.A., a société anonyme organized under the laws of Switzerland (“SPN”).
View on SEC.gov